127 related articles for article (PubMed ID: 30486609)
21. The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients.
Pluta A; Robak T; Cebula B; Majchrzak A; Pluta P; Brzozowski K; Stępka K; Szmigielska-Kapłon A; Grzybowska-Izydorczyk O; Czemerska M; Smolewski P; Wierzbowska A
Arch Med Sci; 2021; 17(3):700-707. PubMed ID: 34025840
[TBL] [Abstract][Full Text] [Related]
22. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
[TBL] [Abstract][Full Text] [Related]
23. Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markers.
Lueck SC; Russ AC; Botzenhardt U; Schlenk RF; Zobel K; Deshayes K; Vucic D; Döhner H; Döhner K; Fulda S; Bullinger L
Oncotarget; 2016 Aug; 7(31):49539-49551. PubMed ID: 27385100
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
Chen P; Li J; Ge LP; Dai CH; Li XQ
Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
[TBL] [Abstract][Full Text] [Related]
25. High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
Chen C; Chio CL; Zeng H; Li Y
Hematology; 2021 Dec; 26(1):210-214. PubMed ID: 33594945
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
Dobrzycka B; Terlikowski SJ; Bernaczyk PS; Garbowicz M; Niklinski J; Chyczewski L; Kulikowski M
Folia Histochem Cytobiol; 2010 Dec; 48(4):678-81. PubMed ID: 21478115
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.
Kim HP; Bernard L; Berkowitz J; Nitta J; Hogge DE
Cytometry B Clin Cytom; 2012 Sep; 82(5):283-94. PubMed ID: 22508650
[TBL] [Abstract][Full Text] [Related]
29. Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia.
Long X; Yu Y; Perlaky L; Man TK; Redell MS
Br J Haematol; 2015 Sep; 170(5):704-18. PubMed ID: 25974135
[TBL] [Abstract][Full Text] [Related]
30. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients.
Aref S; Azmy E; El-Bakry K; Ibrahim L; Mabed M
Hematology; 2018 Jun; 23(5):263-270. PubMed ID: 29161980
[TBL] [Abstract][Full Text] [Related]
32. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
Chromik J; Safferthal C; Serve H; Fulda S
Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
[TBL] [Abstract][Full Text] [Related]
33. Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia.
Raeisi M; Nikhanfar AR; Nejate B; Movassaghpour Akbari AA; Dolatkhah R; Roosta Y; Sanaat Z
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2625-2631. PubMed ID: 31554356
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Significance of CD56 Antigen Expression in Patients with
Sun Y; Wan J; Song Q; Luo C; Li X; Luo Y; Huang X; Ding R; Li H; Hou Y; Huang Y; Xie M; Huang Z; Zhang Y; Ma Y; Wu G; Xu S; Chen J
Biomed Res Int; 2021; 2021():1929357. PubMed ID: 33928145
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis.
Xu S; Li X; Zhang J; Chen J
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1859-70. PubMed ID: 25924702
[TBL] [Abstract][Full Text] [Related]
37. [CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications].
Xu N; Liu XL; DU QF; Liu Z; Zhong M; Lin R; Song LL; Yi ZS; Meng FY; Zhou SY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1605-8. PubMed ID: 19726305
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
Tumour Biol; 2015 Jun; 36(6):4157-65. PubMed ID: 25577253
[TBL] [Abstract][Full Text] [Related]
39. ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemia.
Damm F; Wagner K; Görlich K; Morgan M; Thol F; Yun H; Delwel R; Valk PJM; Löwenberg B; Heuser M; Ganser A; Krauter J
Br J Haematol; 2012 Jul; 158(2):208-215. PubMed ID: 22568493
[TBL] [Abstract][Full Text] [Related]
40. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
Sasca D; Szybinski J; Schüler A; Shah V; Heidelberger J; Haehnel PS; Dolnik A; Kriege O; Fehr EM; Gebhardt WH; Reid G; Scholl C; Theobald M; Bullinger L; Beli P; Kindler T
Blood; 2019 May; 133(21):2305-2319. PubMed ID: 30814062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
